Cargando…
Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme
Enzymes that act on multiple substrates are common in biology but pose unique challenges as therapeutic targets. The metalloprotease insulin-degrading enzyme (IDE) modulates blood glucose levels by cleaving insulin, a hormone that promotes glucose clearance. However, IDE also degrades glucagon, a ho...
Autores principales: | Maianti, Juan Pablo, Tan, Grace A., Vetere, Amedeo, Welsh, Amie J., Wagner, Bridget K., Seeliger, Markus A., Liu, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551522/ https://www.ncbi.nlm.nih.gov/pubmed/31086331 http://dx.doi.org/10.1038/s41589-019-0271-0 |
Ejemplares similares
-
Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin
por: Leissring, Malcolm A., et al.
Publicado: (2010) -
Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
por: Zhang, Zhening, et al.
Publicado: (2018) -
Redox Regulation of Insulin Degradation by Insulin-Degrading Enzyme
por: Cordes, Crystal M., et al.
Publicado: (2011) -
Targeting Insulin-Degrading Enzyme in Insulin Clearance
por: Leissring, Malcolm A., et al.
Publicado: (2021) -
Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme
por: González-Casimiro, Carlos M., et al.
Publicado: (2021)